The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of RNA-sequencing signatures with clinical outcomes of pembrolizumab + chemotherapy in patients with metastatic nonsquamous non–small cell lung cancer (NSCLC) enrolled in the phase 2 KEYNOTE-782 trial.
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Peptomyc; Pfizer; Regeneron; Roche; Sanofi; Takeda; Turning Point Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; Bristol Myers Squibb; Daiichi Sankyo; Genentech; Janssen; Lilly; Medical Trends; Medscape; Merck Serono; Merck Sharp & Dohme; Peervoice; Pfizer; Roche; Sanofi; Takeda; Touch Oncology
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche
Other Relationship - GRIFOLS
(OPTIONAL) Uncompensated Relationships - "ETOP IBCSG Partners" Member of the Scientific Committee; Member of the Scientific Advisory Committee -Hospital Universitari Parc Taulí-; SEOM (Sociedad Española de Oncología Médica), President from 2021-2023
 
Santiago Ponce Aix
Speakers' Bureau - AstraZeneca; Pfizer
 
Jair Bar
Stock and Other Ownership Interests - Causalis
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Immunai (Inst); MSD (Inst); Novartis (Inst); Oncohost (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Emilio Esteban
Travel, Accommodations, Expenses - Pfizer/EMD Serono; Pfizer/EMD Serono
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - AstraZeneca Spain; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - MSD; Roche
 
Tibor Csőszi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Pfizer; Sanofi
 
Maya Gottfried
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Zsuzsanna Szalai
Honoraria - Astra-Zeneca, Berlin-Chemie, Boehringer-Ingelheim, Sanofi, Chiesi, Roche, MSD, BMS
Consulting or Advisory Role - Astra-Zeneca, Berlin-Chemie, Boehringer-Ingelheim, Sanofi, Chiesi, Roche, MSD, BMS
Travel, Accommodations, Expenses - Astra-Zeneca, Berlin-Chemie, Boehringer-Ingelheim, Sanofi, Chiesi, Roche, MSD, BMS
 
Mariano Provencio
Honoraria - AstraZeneca; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck; MSD; Pfizer; Roche; Roche; Takeda
Speakers' Bureau - AstraZeneca; BMS; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD; Pfizer; Pierre Fabre (Inst); Roche (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca; BMS; Boehringer Ingelheim; Bristol Myers Squibb Company; Lilly; MSD; Pierre Fabre; ROCHE; Roche; Takeda
Other Relationship - Pfizer
 
Andrea Fülöp
No Relationships to Disclose
 
Suman Rao
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca; Gilead Sciences; Roche
 
David Ross Camidge
Honoraria - Abbvie; Amgen Astellas BioPharma; Anheart Therapeutics; Apollomics; AstraZeneca; BeiGene; BeiGene; bio-thera; Daiichi Sankyo; Dizal Pharma; Elevation Oncology; EMD Serono; Helsinn Therapeutics; Hengrui Pharmaceutical; Hummingbird; Janssen; Kestrel Labs; Lilly; Mersana; Mirati Therapeutics; nalo therapeutics; Nuvalent, Inc.; OnKure; Puma Biotechnology; Ribon Therapeutics; Roche; Sanofi; Seagen; takeda; Turning Point Therapeutics
Research Funding - Inivata (Inst)
 
Giovanna Speranza
Consulting or Advisory Role - Bayer; Gilead Sciences
 
Scott K. Pruitt
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Steven Matthew Townson
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Julie Kobie
Employment - Merck
Stock and Other Ownership Interests - Merck
 
E.J. Dettman
Employment - Merck
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Patent applications
 
Andrey Loboda
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Michael Nebozhyn
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Merck
 
Andrew George Robinson
Honoraria - Merck
Consulting or Advisory Role - Amgen; AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Roche Canada (Inst)